Add-Life Pharma Ltd (524665) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524665 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Add-Life Pharma Ltd (524665) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524665 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Add-Life Pharma

Based on:

M-Cap below 100cr DeciZen not available

Add-Life Pharma stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
6.9 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Add-Life Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05TTM
ROCE % -11%-10.4%-37.2%-14.2%-0.3%-0%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 10.100.501.61
Sales YoY Gr.--92.3%-50%1,050%-100%NA-
Adj EPS -1.2-1-2-0.6-0-00
YoY Gr.-NANANANANA-
BVPS (₹) 6.96.13.73.19.79.79.7
Adj Net
Profit
-0.6-0.5-1.1-0.3-0.2-0.10
Cash Flow from Ops. 0.20.1-0.20.10-0-
Debt/CF from Ops. 5.616.9-3.510.50-18.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA9.4%244.1%NA
Adj EPS NANANANA
BVPSNA7.2%38%0%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05TTM
Return on
Equity %
-14.7-13.4-35.2-16.1-0.3-00
Op. Profit
Mgn %
-33.4-377.3-1742.4-35.503.17.3
Net Profit
Mgn %
-59.2-665.9-2477.9-74.20-2.80
Debt to
Equity
0.30.30.40.300-
Working Cap
Days
04,0895,87338001010
Cash Conv.
Cycle
03,6685,061-2370370

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Add-Life Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 1.1 -
BVPS (₹.) 9.7 -
Reserves (₹ Cr.) -4 -
P/BV 0.05 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) 0.46 / 37.50
Market Cap (₹ Cr.) 6.9
Equity (₹ Cr.) 149.2
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Add-Life Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Add-Life Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Add-Life Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'04Mar'05
Sales1.040.080.040.4601.63
Operating Expenses 1.390.381.190.730.131.58
Manufacturing Costs0.350.110.200.0100
Material Costs0.550.030.340.4801.43
Employee Cost 0.070.050.05000.02
Other Costs 0.420.190.600.250.130.13
Operating Profit -0.36-0.30-1.14-0.28-0.130.05
Operating Profit Margin (%) -34.5%-381.0%-2,701.9%-61.0%-3.1%
Other Income 00.020.050.0500
Interest 0.120.080.080.0700
Depreciation 0.150.170.160.120.100.10
Exceptional Items 000000
Profit Before Tax -0.62-0.53-1.33-0.42-0.22-0.05
Tax 000000
Profit After Tax -0.62-0.53-1.33-0.42-0.22-0.05
PAT Margin (%) -60.0%-668.0%-3,149.3%-92.1%--2.8%
Adjusted EPS (₹)-1.2-1.0-2.5-0.8-0.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'04Mar'05

Equity and Liabilities

Shareholders Fund 4.183.652.311.90145.80145.75
Share Capital 5.265.265.265.26149.76149.76
Reserves -1.08-1.61-2.94-3.36-3.96-4.01
Minority Interest000000
Debt0.980.820.790.530.480.47
Long Term Debt0.980.820.790.530.480.47
Short Term Debt000000
Trade Payables000.310.310.250.25
Others Liabilities 0.130.210.090.020.020.02
Total Liabilities 5.284.683.512.76146.56146.49

Fixed Assets

Gross Block3.853.832.982.702.222.22
Accumulated Depreciation0.430.600.590.660.680.78
Net Fixed Assets 3.423.242.382.041.541.44
CWIP 0.040.040000
Investments 0.010.010.010.01144.50144.51
Inventories0.730.700.48000.02
Trade Receivables0.15000.340.340.50
Cash Equivalents 0.290.140.170.050.030
Others Assets 0.640.550.460.320.150.02
Total Assets 5.284.683.512.76146.56146.49

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'05
Cash Flow From Operating Activity 0.170.05-0.220.05-0.03
PBT -0.62-0.53-1.33-0.42-0.05
Adjustment 0.370.320.690.350.19
Changes in Working Capital 0.430.250.420.12-0.17
Tax Paid 00000
Cash Flow From Investing Activity 0.170.030.370.160
Capex -0.030.010.280.110
Net Investments 00000
Others 0.200.020.090.050
Cash Flow From Financing Activity -0.31-0.23-0.11-0.340
Net Proceeds from Shares 00000
Net Proceeds from Borrowing -0.08-0.15-0.01-0.160
Interest Paid -0.12-0.08-0.08-0.070
Dividend Paid 00000
Others -0.110-0.02-0.110
Net Cash Flow 0.04-0.150.04-0.13-0.03

Finance Ratio

PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'04Mar'05
Ratios
ROE (%)-17.17-15.48-51.92-23.53-0.3-0.03
ROCE (%)-10.99-10.41-37.22-14.17-0.3-0.03
Asset Turnover Ratio0.20.020.010.1500.01
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days5234818137094
Inventory Days2583,3205,091004
Payable Days00170240065

Add-Life Pharma Ltd Stock News

Add-Life Pharma Ltd FAQs

The current trading price of Add-Life Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Add-Life Pharma stood at ₹6.86.
The latest P/E ratio of Add-Life Pharma as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Add-Life Pharma as of 31-Dec-1969 is 0.05.
The 52-week high of Add-Life Pharma is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Add-Life Pharma is ₹1.12 ( Cr.) .

About Add-Life Pharma Ltd

Add-Life Pharma Limited (ADDLP) which was initially incorporated as a private limited company on January 11, 1991, was promoted by Shri Ishwarbhai Patel, Shri Rameshbhai Patel and their associates. Subsequently, it was reorganized with the induction of Dr Bharat I Patel in September, 1992 and the Company was converted into AddLife Pharma Limited on May 17, 1993.

The company is involved in the production of pharmaceuticals. The firm manufactures Ethambutol HCL, an anti-Tuberculosis drug, cotton dressings, and drug intermediaries at its manufacturing unit situated in Mehsana district of Gujarat. The drug Ethambutol HCL, manufactured by the firm, enjoys a decent standing and is suitably acknowledged in the pharma market. The drug has been removed from BSE in relation of non acquiescence with registering concurrence clauses.

The registered office is located at 412-2/C, Payal Complex, Opposite Fortune Towers, Sayajigunj, Vadodara-390005, Gujarat.

Product Portfolio

  • Ethambutol
  • L2 Amino Butanol
  • Sodium Naphthionate
  • Chemical Intermediate
  • Other Raw Materials
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×